International In Brief
This article was originally published in The Gray Sheet
EU upclassifications: An initiative to bump hip, knee and shoulder replacements in Europe from Class IIb to the higher-risk Class III may serve as a model for reclassifications down the road, said Ibim Tariah of BSI Management Systems at the Sept. 28-29 AdvaMed 2005 International Conference in Washington, D.C. (1"The Gray Sheet" Sept. 9, 2005, p. 9). Tariah suggested that a breast implant upclassification in 2003 was "a test case" involving a relatively small number of manufacturers. By contrast, the pending orthopedic reclassification affects "some of the big medical device companies of the world, and there's no doubt about it [that] it's going to pose a much greater challenge...and will possibly be the gold standard that could be used should a situation like this arise in the future," Tariah said...
You may also be interested in...
Manufacturers should start submitting design dossiers to notified bodies for their hip, knee and shoulder replacements to be reclassified as Class III devices in the European Union, according to BSI Americas VP Paul Brooks
Small and mid-size device companies seeking product approval in Japan will encounter resistance to international trial data, according to Pacific Bridge Medical (PBM) President Ames Gross
Faster reviews of low-risk medical devices in Japan are on the horizon as the fledgling Pharmaceutical & Medical Devices Agency prepares to implement new review processes, effective April 1